EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSOTSG00005010271
Gene Symbol: ADRA2A
3 Cross references
153 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOTSG00005026401
Gene Symbol: ADRA2A
1 Cross references
171 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOTSG00005020388
Gene Symbol: ADRA2B
1 Cross references
168 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOTSG00005015189
Gene Symbol: ADRA2B
1 Cross references
145 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOTSG00005006544
Gene Symbol: ADRA2B
1 Cross references
169 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOTSG00005001906
Gene Symbol: ADRA2C
1 Cross references
151 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOTSG00005047945
Gene Symbol: ADRA2C
1 Cross references
151 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSOTSG00005039085
Gene Symbol: ADRB2A
1 Cross references
190 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSOTSG00005004018
Gene Symbol: ADRB2B
1 Cross references
186 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSOTSG00005006040
Gene Symbol: ADRB2B
1 Cross references
186 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSOTSG00005016212
Gene Symbol: ADRB3A
1 Cross references
190 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSOTSG00005040926
Gene Symbol: ADRB3B
1 Cross references
144 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).